Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Liabilities and Shareholders Equity (2022 - 2026)

GE HealthCare Technologies posted quarterly Liabilities and Shareholders Equity of $37.1 billion for Q1 2026, up 10.54% year-on-year from $33.6 billion in Q1 2025, and up 0.59% on a QoQ basis from $36.9 billion in Q4 2025.

GE HealthCare Technologies (GEHC) has 5 years of Liabilities and Shareholders Equity data on file, last reported at $37.1 billion in Q1 2026.

  • For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 10.54% year-over-year to $37.1 billion; the trailing twelve-month figure through Mar 2026 stood at $145.7 billion (up 10.03% YoY), and the FY2025 full-year result was $36.9 billion, up 11.54% from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 stood at $37.1 billion, up from $36.9 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $37.1 billion in Q1 2026 and bottomed at $27.5 billion in Q4 2022.
  • The 5-year median for Liabilities and Shareholders Equity is $32.9 billion (2023), against an average of $33.4 billion.
  • The widest annual swing landed in 2023, when Liabilities and Shareholders Equity increased 17.85%; it then dropped 1.42% in 2024.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $27.5 billion in 2022, then climbed by 17.85% to $32.5 billion in 2023, then climbed by 1.96% to $33.1 billion in 2024, then gained by 11.54% to $36.9 billion in 2025, then climbed by 0.59% to $37.1 billion in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $37.1 billion (Q1 2026), $36.9 billion (Q4 2025), and $36.1 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 110.43 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 46.29 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 91.49 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 13.32 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 31.92 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 6.63 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 37.13 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 10.74 Bn
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn 22.72 Bn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 37.13 Bn
Dec 31, 2025 36.91 Bn
Sep 30, 2025 36.13 Bn
Jun 30, 2025 35.50 Bn
Mar 31, 2025 33.59 Bn
Dec 31, 2024 33.09 Bn
Sep 30, 2024 33.86 Bn
Jun 30, 2024 31.85 Bn
Mar 31, 2024 32.21 Bn
Dec 31, 2023 32.45 Bn
Sep 30, 2023 32.38 Bn
Jun 30, 2023 32.31 Bn
Mar 31, 2023 32.64 Bn
Dec 31, 2022 27.54 Bn